학술논문

ELUXA 1: Ph II study of BI1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)
Document Type
Journal
Source
CANCER RESEARCH; JUL 2016, 76 4p. Supplement: 14
Subject
Language
English
ISSN
15387445